A new blood test to detect biomarkers for Alzheimer's disease is set to undergo trials in the Fall. The test will be able to identify traces of amyloid beta in blood samples with a high degree of accuracy.
Neurofilament light protein in plasma may be a noninvasive biomarker for neurodegeneration associated with Alzheimer's disease.
Researchers report they have discovered where the earliest signs of Alzheimer's may occur in the brain. Initial accumulation of Alzheimer's associated amyloid beta was discovered in an important functional network, the default mode network.
Researchers at Lund University have developed a new imaging method that can help doctors detect and track Alzheimer's disease in people of different ages more effectively.
Researchers reveal the social divide between chimps and humans isn't as clear cut as once thought. Observing both animals and visitors at a zoo, researchers discovered about 10% of the actions produced by one species was an imitation of the other species.
A new study reports mindfulness group therapy has an equally positive effect for people suffering with depression and anxiety disorders as individual cognitive behavioral therapy.
An experiment aimed to investigate how the brain interprets artificial touch sensation from a finger neuroprosthesis, has revealed new information for developing way to measure brain health.
New technology allows researchers to produce images that predate the formation of amyloid beta in the brain. The findings have prompted researchers to suggest stabilizing the protein, rather than attempting to limit it, in order to reduce Alzheimer's symptoms.